Washington legislation · 2025-26 Regular Session
Washington SB5240: Anaphylaxis med. in schools
Status: Passed one chamber, March 12, 2026
Concerning anaphylaxis medications in schools.
What the bill says
An act Relating to anaphylaxis medications in schools; and amending RCW 28A.210.383 and 28A.210.380.
From the introduced text:
AN ACT Relating to anaphylaxis medications in schools; and amending RCW 28A.210.383 and 28A.210.380. Sec. 1. RCW 28A.210.383 and 2024 c 81 s 2 are each amended to read as follows: (1) School districts and ((nonpublic))private schools may maintain at a school in a designated location a supply of epinephrine ((and)), including epinephrine autoinjectors, based on the number of students enrolled in the school. (2)(a) A licensed health professional with the authority to prescribe epinephrine, including, but not limited to, the secretary of health or the secretary's designee in accordance with RCW 43.70.827, may prescribe epinephrine, including epinephrine autoinjectors, in the name of the school district or school to be maintained for use when necessary. Epinephrine prescriptions must be accompanied by a standing order issued in accordance with this section or RCW 43.70.827 for the administration of school-supplied, undesignated epinephrine and epinephrine autoinjectors for potentially life-threatening allergic reactions. (b) There are no changes to current prescription or self-administration practices for children with existing epinephrine autoinjector prescriptions or a guided anaphylaxis care plan. (c) Epinephrine and epinephrine autoinjectors may be obtained from donation sources, but must be accompanied by a prescription. (3)(a) When a student has a prescription for ((an)) epinephrine ((autoinjector)) on file, the school nurse may utilize the school district or school supply of epinephrine, authorized under subsection (1) …
Sponsors
- Lisa Wellman (D) · primary sponsor
- Vandana Slatter (D)
- Matt Boehnke (R)
- Robert Hasegawa (D)
- T'wina Nobles (D)
- Derek Stanford (D)
- Yasmin Trudeau (D)
- Wilson, Claire (D, 30)
Latest actions
- : By resolution, returned to Senate Rules Committee for third reading.
- : Rules Committee relieved of further consideration. Placed on second reading.
- : Referred to Rules 2 Review.
- : ED - Majority; do pass with amendment
- : Executive action taken in the House Committee on Education at 1:30 PM.
- : Public hearing in the House Committee on Education at 10:30 AM.
- : First reading, referred to Education.
- : Third reading, passed; yeas, 49; nays, 0; absent, 0; excused, 0.
- : Placed on third reading by Rules Committee.
- : By resolution, reintroduced and retained in present status.
Votes
- House Committee on Education: Do pass as amended (February 23, 2026): 19 yea, 0 nay, passed
- Final Passage (January 21, 2026): 49 yea, 0 nay, passed
- 3rd Reading & Final Passage (March 10, 2025): 49 yea, 0 nay, passed
- Senate Committee on Early Learning & K-12 Education: That Substitute Senate Bill No. 5240 be substituted therefor, and the substitute bill do pass (February 11, 2025): 9 yea, 0 nay, passed
Subjects: SCHOOLS AND SCHOOL DISTRICTS
Common questions
- What is SB5240?
- SB5240 is a bill in the Washington Legislature (2025-26 Regular Session): Anaphylaxis med. in schools.
- What does SB5240 do?
- In its own words: An act Relating to anaphylaxis medications in schools; and amending RCW 28A.210.383 and 28A.210.380.
- What is the status of SB5240?
- Passed one chamber as of March 12, 2026. Latest action: By resolution, returned to Senate Rules Committee for third reading. (March 12, 2026).
- Who sponsored SB5240?
- Lisa Wellman (D), with 7 co-sponsors.
- Where is the official record for SB5240?
- On the Washington Legislature website: https://app.leg.wa.gov/billsummary?BillNumber=5240&Year=2025
Source: official Washington record. Tracked by Delilah, AI for legislation across all 50 states and Congress.